Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

View all journals
Search
Log in

nature
search

Search

Advanced search

Filter By:

Journal Check one or more journals to show results from those journals only.

Nature Immunology (2)
Nature Communications (1)

Choose more journals

Article type Check one or more article types to show results from those article types only.

News & Views (1)
Research (1)
Reviews (1)

Subject Check one or more subjects to show results from those subjects only.

Cancer
Cell biology
Immunology

Date Choose a date option to show results from those dates only.

Today
Last 7 days
Last 30 days
Last 12 months
Last 2 years
Last 5 years

Custom date range

Clear all filters

Sort by:

Relevance

Date published (new to old)

Date published (old to new)

Showing 1–3 of 3 results

Advanced filters: Author: Camille Guillerey Clear advanced filters

Mitochondrial reactive oxygen species regulate the induction of CD8⁺ T cells by plasmacytoid dendritic cells

Cross-presentation allows exogenous antigens to be presented by the major histocompatibility I pathway. Here the authors show that the inducible cross-presentation by plasmacytoid dendritic cells is modulated by mitochondria-originated reactive oxygen species.

Marine Oberkampf
Camille Guillerey
Gilles Dadaglio
ResearchOpen Access08 Jun 2018
Nature Communications

Volume: 9, P: 1-14
Cytokine-driven role of Srebps in killer cell metabolism

A new and unexpected role is identified for Srebps in controlling NK cell activity that is independent of their role in lipid biosynthesis.

Camille Guillerey
Mark J Smyth
News & Views18 Oct 2017
Nature Immunology

Volume: 18, P: 1183-1184
Targeting natural killer cells in cancer immunotherapy

There is now a major effort to fully exploit the anti-tumor properties of NK cells in the clinic. In this Review, Smyth and colleagues detail recent advances in NK cell–based immunotherapies and discuss the advantages and limitations of these strategies.

Camille Guillerey
Nicholas D Huntington
Mark J Smyth
Reviews19 Aug 2016
Nature Immunology

Volume: 17, P: 1025-1036